On the other hand, there are four variables in both models with a decreasing effect on the hazard ratio if their value is increased (intake of drugs to treat benign prostatic hypertrophy, treated dyslipidemia, IGF-1 and female sex). The gene discussed is IGF1; the disease is benign prostatic hyperplasia.